Warner, B. M., Vendramelli, R., Boese, A. S., Audet, J., Tailor, N., Meilleur, C., . . . Kobasa, D. Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationWarner, Bryce M., et al. Treatment with the CCR5 Antagonist OB-002 Reduces Lung Pathology, but Does Not Prevent Disease in a Syrian Hamster Model of SARS-CoV-2 Infection. Public Library of Science (PLoS).
MLA (9th ed.) CitationWarner, Bryce M., et al. Treatment with the CCR5 Antagonist OB-002 Reduces Lung Pathology, but Does Not Prevent Disease in a Syrian Hamster Model of SARS-CoV-2 Infection. Public Library of Science (PLoS).
Warning: These citations may not always be 100% accurate.